{
  "directed": true,
  "graph": {
    "annotation_list": {
      "AssayType": [
        "B"
      ],
      "MeasurementRelation": [
        "="
      ],
      "MeasurementType": [
        "Ki"
      ],
      "MeasurementUnits": [
        "nM"
      ],
      "MeasurementValue": [
        "1.3",
        "1.4",
        "1.9"
      ]
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Kristian Kolpeja",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "In Vivo and In Vitro Characterization of Antalarmin, a Nonpeptide Corticotropin-Releasing Hormone (CRH) Receptor Antagonist: Suppression of Pituitary ACTH Release and Peripheral Inflammation",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "CL": "^\\d{7}$",
      "DBSNP": "rs[0-9]+"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "namespaces_uncached": [],
    "path": "antalarmin/lewis1996.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "30c806c9625631a300e27d1704595f3ee23e12fcc9adbcae8ddb903580486ae767206c1949e2eecbaa4bce1c02007b230ff5a1ce61abb30a6eab9807dd792c14",
      "line": 81,
      "relation": "regulates",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "feeec5f81a6c25cd7bc019e16dc15c12c5bc646b9a278a1fed5538102f153692334212a93aaccae7e4ccf1bd70213275fbc3748b6c1deda3617bfa585c59cb17",
      "line": 82,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "530e2b124518f599ab9adfcbfec36061805a001cc49a77bbac352a410d2df3d25665d1306aff075c24dce3797ce2be55552804c2497073a3cbebe2d8f2e5c24c",
      "line": 83,
      "relation": "positiveCorrelation",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "40a04dbabe438b8b8fafdfdc7bd04708f737b6736872da95889695d708e494d3cfc3126236b9304b4a8d0a9762dd91fc6ae16addbcbc4b19e65753f46ca79cb1",
      "line": 99,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyIncreases",
      "source": 4,
      "subject": {
        "modifier": "Activity"
      },
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "hypothalamus": true
        },
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Corticotropin-releasing hormone (CRH) secreted from the hypothalamus is the major regulator of pituitary ACTH release and consequent glucocorticoid secretion. CRH secreted in the periphery also acts as a proinflammatory modulator.",
      "key": "0dcc3379615f5232a3fba98e915705dee2430979d68309bf900dc1e0a32fb0760202258b17b3d8fa37fec9eb563c5163707e3bef2b6aad3c4576675f26f3575e",
      "line": 83,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 3,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "key": "e4b30e052332aa2e3a46c7499d492da0ea5606dbeb371da05994d7ee0160bd3a7c1df587500016b50ad7c7741053141c026969986cf73f62c0017c5e785406a3",
      "line": 128,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "1d22d26c4f1fff94b2cf854e6398ca4615577c51747a04939e8fdec58ea987cf7fdbb028bfe3bc3268872d27e8d7f6a1772a598ad29992755114b358cd572cc8",
      "line": 98,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyDecreases",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Indeed, the compound significantly suppressed (XI-l-induced ACTH secretion to approximately the same extent as neutralizing polyclonal anti-CRH.",
      "key": "d9203bbc9f15ca3f0805ec00cef4f5365685c66b9346aee5b76c143695364a4a5dd6423a3a688b7eef3c5379f1dbcbf863c349f04d281e6d017f533ced050f66",
      "line": 135,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "pituitary gland": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "MeasurementValue": {
          "1.9": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "3f8dfcae335a7949fe86a4766cc69ba2dda3f8fc6fc0462731d2a07f69cb3bb41255bb00584cb62d1337b8e5003b350d01ee7cbf0f3d9a8d683922c35d776e7c",
      "line": 100,
      "object": {
        "modifier": "Activity"
      },
      "relation": "directlyDecreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "These results raise the possibility that pyrrolopyrimidine compounds, such as antalarmin, which antagonize CRH at the level of its own receptor, have therapeutic potential in some forms of inflammation.",
      "key": "8bd32354bc87fa37ddeed0483100685d15a9543f75ef82c7a915e54c3d868407a05d94a7a1909ea76810e6822dc382a677c87725e0df0fd59da319ed59aaaa28",
      "line": 128,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 3
    },
    {
      "annotations": {
        "Anatomy": {
          "frontal cortex": true
        },
        "AssayType": {
          "B": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeasurementRelation": {
          "=": true
        },
        "MeasurementType": {
          "Ki": true
        },
        "MeasurementUnits": {
          "nM": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Chrousos GP",
          "Lewis DB",
          "Rice KC",
          "Torpy DJ",
          "Webster EL",
          "Zachman EK"
        ],
        "date": "1996-12-01",
        "first": "Webster EL",
        "last": "Chrousos GP",
        "name": "Endocrinology",
        "pages": "5747-50",
        "reference": "8940412",
        "title": "In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.",
        "type": "PubMed",
        "volume": "137"
      },
      "evidence": "Antalarmin potently displaced 1251-oCRH binding, exhibiting respectively Ki values of 1. 9 f 0.9,. 1.3 f .4, and 1.4 f .6 nM (mean f SEM) in pituitary, cerebellum, and frontal cortex homogenates.Antalarmin, by effectively displacing IoCRH binding in tissues predominately expressing CRHRl but not in tissues expressing CRHR2, appears to be a specific CRHRl receptor antagonist.",
      "key": "4d7a8169711c6811ec5d29226fb8602474a3ae5b8a1295e09d65efb2adc2a231c0449e6f448eb62bb6e8d204f754279805f50944edc9f744996d35535894c11a",
      "line": 116,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 6,
      "subject": {
        "modifier": "Activity"
      },
      "target": 5
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:antalarmin)",
      "function": "Abundance",
      "id": "28e79e7132b24ce51158bb2dc3f9f390011d94eeeb2f659bebb29ae2402a97fea0953d1185cb0551e0d9c243579ecda82a908b0b00073d050e4a28ca647c05ce",
      "name": "antalarmin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(MESH:\"Adrenocorticotropic Hormone\")",
      "function": "Abundance",
      "id": "cf288cf6a749a597d4cfbcac32847b7708bef0b64df47cdaf894dacc36f6089e3a00098a906596159e357b902b46650d7ddc70681b9845c08add7f727c45effe",
      "name": "Adrenocorticotropic Hormone",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Glucocorticoids)",
      "function": "Abundance",
      "id": "abcbf36a76bd1cbe9767c48e56070ed109d78639742058342073bacbeebb78f939b84f3681d4ba456b5cf88d5a42546d4585c4f49018edd879895b9a027b0c52",
      "name": "Glucocorticoids",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "function": "BiologicalProcess",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "name": "inflammatory response",
      "namespace": "GO"
    },
    {
      "bel": "p(RGD:Crh)",
      "function": "Protein",
      "id": "3f843a4cf4dc22cef31ce5ee461be73605c83880dc97a543da609e77d24862368f5a5d31719d535467e386ad8e40e17ca0c355b8ab9bea90a22e29d16d41f58e",
      "name": "Crh",
      "namespace": "RGD"
    },
    {
      "bel": "p(RGD:Crhr1)",
      "function": "Protein",
      "id": "5fda058086d8734f622658f82b9bae354a376917eeee1f979cbb6929d7e135b5a4d3c26da72495d13775cf14bdc48347d6e55e2463554ba6541508e7d9981fa9",
      "name": "Crhr1",
      "namespace": "RGD"
    },
    {
      "bel": "p(RGD:Crhr2)",
      "function": "Protein",
      "id": "f6f5b44c97267ad892c218b490edd04190a42bb9f48d34e46628687fb50fa974edf824165d30ca8ce603bca949290f57ec4d0a5b14552d9782b491e944d708a0",
      "name": "Crhr2",
      "namespace": "RGD"
    }
  ]
}